4 Results

People

  1. Kris
    Kris
  2. Oxnard
    Oxnard
  3. Miller
    Miller
  4. Riely
    Riely
  5. Sima
    Sima
  6. Pao
    Pao
  7. Arcila
    Arcila
  8. Azzoli
    Azzoli
  9. Chaft
    Chaft
  10. Clarke
    Clarke

Groups

  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Radiology, Department of (2)
  5. Body Imaging Service (1)
  6. GSK Faculty (1)
  7. Gastrointestinal Oncology Service (1)
  8. Human Oncology and Pathogenesis Program (1)
  9. Neuroradiology Service (1)
  10. Tow Center for Developmental Oncology (TCDO) (1)
  1. "clinical article"
  2. "Geoffrey Oxnard"
  3. "2011"
Formats
  1. Journal Article (4)
Groups
  1. Department of Medicine (4)
  2. Solid Tumor Oncology Division (4)
  3. Thoracic Oncology (4)
  4. Radiology, Department of (2)
  5. Body Imaging Service (1)
  6. GSK Faculty (1)

More Groups

People
  1. Geoffrey Oxnard (4)
  2. Mark Kris (4)
  3. Camelia Sima (3)
  4. Gregory Riely (3)
  5. Vincent Miller (3)
  6. William Pao (2)

More People

Years
  1. 2011 (4)
Publications
  1. Clinical Cancer Research (2)
  2. Journal of Clinical Oncology (1)
  3. Neuro-Oncology (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Oxford University Press (1)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pulsatile high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer
    Journal Article

    Grommes, C.; Oxnard, G. R.; Kris, M. G.; Miller, V. A.; Pao, W.; Holodny, A. I.; Clarke, J. L.; Lassman, A. B.
    Neuro-Oncology (2011)

    Fulltext@MSK | Save
  • Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib
    Journal Article

    Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Sima, C. S.; Kass, S. L.; Riely, G. J.; Pao, W.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Disease flare after tyrosine kinase inhibitor discontinuation in patients with EGFR-mutant lung cancer and acquired resistance to erlotinib or gefitinib: Implications for clinical trial design
    Journal Article

    Chaft, J. E.; Oxnard, G. R.; Sima, C. S.; Kris, M. G.; Miller, V. A.; Riely, G. J.
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Variability of lung tumor measurements on repeat computed tomography scans taken within 15 minutes
    Journal Article

    Oxnard, G. R.; Zhao, B.; Sima, C. S.; Ginsberg, M. S.; James, L. P.; Lefkowitz, R. A.; Guo, P.; Kris, M. G.; Schwartz, L. H.; Riely, G. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save